Stealth BioTherapeutics Corp filed its 20-F on Apr 07, 2022 for the period ending Dec 31, 2021. In this report its auditor, Deloitte & Touche LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Stealth BioTherapeutics Corp
Equities
MITO
US85789A1051
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
+54.05% | 5.87TCr | |
-2.02% | 4.13TCr | |
+37.66% | 3.92TCr | |
-10.22% | 2.74TCr | |
+13.42% | 2.65TCr | |
-21.60% | 1.9TCr | |
+2.89% | 1.25TCr | |
+22.40% | 1.19TCr | |
+27.49% | 1.21TCr |